PCM
PRVL

Penserra Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Penserra Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-785
Closed -$18K – 1156
2020
Q4 		$18K Buy
785
+493
+169% +$11.3K ﹤0.01% 864
2020
Q3 		$2K Buy
+292
New +$2K ﹤0.01% 916